Clinical Trial Update: New and Emerging Therapies for the Treatment of Resectable, Borderline Resectable, or Locally Advanced Pancreatic Cancer, PIONEER-Panc Study [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update for the PIONEER-Panc study evaluating new and emerging therapies for pancreatic cancer at various stages (resectable to locally …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Borderline Resectable Pancreatic Adenocarcinoma
• Pancreatic Ductal Adenocarcinoma
• Resectable Pancreatic Ductal Adenocarcinoma

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic Ductal Adenocarcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING